Your browser doesn't support javascript.
loading
Concomitant anti-platelet therapy in warfarin-treated patients undergoing cardiac rhythm device implantation: A secondary analysis of the BRUISE CONTROL trial.
Essebag, Vidal; AlTurki, Ahmed; Proietti, Riccardo; Healey, Jeff S; Wells, George A; Verma, Atul; Krahn, Andrew D; Simpson, Christopher S; Ayala-Paredes, Felix; Coutu, Benoit; Leather, Richard; Ahmad, Kamran; Toal, Satish; Sapp, John; Sturmer, Marcio; Kavanagh, Katherine; Crystal, Eugene; Leiria, Tiago L L; Seifer, Colette; Rinne, Claus; Birnie, David.
  • Essebag V; McGill University Health Centre, Montreal, Quebec, Canada; Hôpital Sacré-Coeur de Montréal, Montreal, Quebec, Canada. Electronic address: vidal.essebag@mcgill.ca.
  • AlTurki A; McGill University Health Centre, Montreal, Quebec, Canada.
  • Proietti R; Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, Padua, Italy.
  • Healey JS; Population Health Research Institute, Hamilton, Ontario, Canada.
  • Wells GA; University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
  • Verma A; Southlake Regional Health Centre, Newmarket, Ontario, Canada.
  • Krahn AD; Division of Cardiology, University of British Columbia, Vancouver, Canada.
  • Simpson CS; Queen's University and Kingston General Hospital, Kingston, Ontario, Canada.
  • Ayala-Paredes F; Université de Sherbrooke, Sherbrooke, Quebec, Canada.
  • Coutu B; Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
  • Leather R; Royal Jubilee Hospital, Victoria, British Columbia, Canada.
  • Ahmad K; St Michael's Hospital, Toronto, Ontario, Canada.
  • Toal S; New Brunswick Heart Center, St John, New Brunswick, Canada.
  • Sapp J; Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada.
  • Sturmer M; Hôpital Sacré-Coeur de Montréal, Montreal, Quebec, Canada.
  • Kavanagh K; Libin Cardiovascular Institute of Alberta, Calgary, Alberta, Canada.
  • Crystal E; Sunnybrook Health Science Centre, Toronto, Ontario, Canada.
  • Leiria TLL; Instituto de Cardiologia Fundação Universitaria Cardiologia, Porto Alegre, Brazil.
  • Seifer C; University of Manitoba, Winnipeg, Manitoba, Canada.
  • Rinne C; St Mary's General Hospital, Kitchener, Ontario, Canada.
  • Birnie D; University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Int J Cardiol ; 288: 87-93, 2019 08 01.
Article en En | MEDLINE | ID: mdl-31056413
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Marcapaso Artificial / Arritmias Cardíacas / Tromboembolia / Warfarina / Aspirina / Desfibriladores Implantables / Hematoma Tipo de estudio: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies País como asunto: America do norte Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Marcapaso Artificial / Arritmias Cardíacas / Tromboembolia / Warfarina / Aspirina / Desfibriladores Implantables / Hematoma Tipo de estudio: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies País como asunto: America do norte Idioma: En Año: 2019 Tipo del documento: Article